Dearborn Partners LLC Sanofi Transaction History

Dearborn Partners LLC

$2.42 Billion
Q3 2024

A detailed history of Dearborn Partners LLC transactions in Sanofi stock. As of the latest transaction made, Dearborn Partners LLC holds 5,595 shares of SNY stock, worth $289,429. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,595

Previous 5,548 0.85%

Holding current value

$289,429

Previous $269,000 19.7%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$48.54 - $58.53 $2,281 - $2,750	47 Added 0.85%	5,595 $322,000
Q1 2024 May 08, 2024	BUY	$45.75 - $52.48 $13,038 - $14,956	285 Added 5.42%	5,548 $269,000
Q4 2023 Jan 26, 2024	SELL	$43.13 - $54.79 $50,634 - $64,323	-1,174 Reduced 18.24%	5,263 $261,000
Q3 2023 Nov 01, 2023	BUY	$50.95 - $55.2 $6,368 - $6,900	125 Added 1.98%	6,437 $345,000
Q2 2023 Aug 03, 2023	SELL	$50.45 - $57.18 $7,819 - $8,862	-155 Reduced 2.4%	6,312 $340,000
Q1 2023 May 04, 2023	BUY	$45.86 - $54.45 $6,282 - $7,459	137 Added 2.16%	6,467 $351,000
Q4 2022 Feb 02, 2023	BUY	$38.86 - $48.55 $621 - $776	16 Added 0.25%	6,330 $306,000
Q3 2022 Oct 25, 2022	BUY	$37.22 - $100.5 $235,007 - $634,557	6,314 New	6,314 $240,000
Q1 2022 May 04, 2022	BUY	$48.48 - $53.65 $10,035 - $11,105	207 Added 3.5%	6,115 $314,000
Q4 2021 Jan 28, 2022	BUY	$47.07 - $52.35 $12,614 - $14,029	268 Added 4.75%	5,908 $296,000
Q3 2021 Oct 27, 2021	BUY	$47.89 - $53.12 $957 - $1,062	20 Added 0.36%	5,640 $272,000
Q3 2020 Oct 20, 2020	SELL	$49.47 - $53.77 $8,954 - $9,732	-181 Reduced 3.12%	5,620 $282,000
Q2 2019 Jul 29, 2019	BUY	$40.43 - $44.3 $234,534 - $256,984	5,801 New	5,801 $251,000

Others Institutions Holding SNY

# of Institutions

810

Shares Held

254M

Call Options Held

2.6M

Put Options Held

1.64M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $130B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Account

Dearborn Partners LLC Sanofi Transaction History